Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | ASB2 |
| Upstream (Parents) |
|---|
| (<<) ARHGAP25 → ASB2 |
| (<<) BLNK → ASB2 |
| (<<) CBFA2T3 → ASB2 |
| (<<) CD79A → ASB2 |
| (<<) CORO1A → ASB2 |
| (<<) GBP2 → ASB2 |
| (<<) GRK6 → ASB2 |
| (<<) ITGB7 → ASB2 |
| (<<) MAL → ASB2 |
| (<<) PAK6 → ASB2 |
| (<<) PARP10 → ASB2 |
| (<<) PRKCB → ASB2 |
| (<<) PRKCH → ASB2 |
| (<<) PTK2B → ASB2 |
| (<<) RAC2 → ASB2 |
| (<<) SH2D2A → ASB2 |
| (<<) STAT6 → ASB2 |
| (<<) TMEM175 → ASB2 |
| (<<) VAV1 → ASB2 |
| Downstream (Children) |
|---|
| ASB2 → EPHB6 (>>) |
| ASB2 → GNG12 (>>) |
| ASB2 → KISS1R (>>) |
| ASB2 → PIP4K2A (>>) |
| ASB2 → SLMO2 (>>) |
| ASB2 → SOCS6 (>>) |
| ASB2 → SOX2 (>>) |
| ASB2 → TSC22D1 (>>) |
| ASB2 → ZBED3 (>>) |
